
AI-powered drug discovery is outpacing regulators, with Eric...
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Newsletters and Deep Dive digital magazine
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
Successful use of AI is becoming a key differentiator for pharma companies.
At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.
Editor's Picks
Newsletters and Deep Dive
digital magazine